MS drug approved by NICE after NHS renegotiates price

A new drug to treat some adults with multiple sclerosis is now being  recommended for use by the National Institute for Health and Care Excellence after the NHS renegotiated a lower price with the manufacturer Roche.
Source: The Pharmaceutical Journal - Category: Drugs & Pharmacology Source Type: research